Single Dose of Psychedelic Compound Shows Promise for Hard-to-Treat Anxiety
-
A single 100 microgram dose of MM120 (lysergic acid diethylamide) led to a 48% remission rate from generalized anxiety disorder after 12 weeks in a recent MindMed study.
-
65% of patients in the study saw anxiety improvements within 3 months of the single MM120 dose.
-
The MM120 effects were more than double current anxiety treatments, occurring at all levels of anxiety from moderate to severe.
-
Some patients reported mild side effects like euphoria, hallucinations, or nausea on the day of taking MM120.
-
The drug will still need to go through standard FDA approval, but will soon enter phase 3 trials based on the promising phase 2 results.